Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 13, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2021. Go to the latest filing (Q3 2026)

12.3B USDQ2 2021
Total value of stock positions
12.3B USD
Positions
58
Share of the ten largest
68.2%

The ten largest positions Q2 2021

  1. Liberty Global PLC 11.9%▼ −1.1%
  2. Intel 9.9%▼ −6.7%
  3. eBay Inc. 8.5%▼ −18.7%
  4. Qorvo Inc 8.5%▲ +2.1%
  5. Viasat Inc 6.6%unchanged
  6. Alphabet Inc. (Class C) 5.9%unchanged
  7. Micron Technology 5.0%▲ +32.1%
  8. Meta Platforms 4.4%▲ +19.3%
  9. Translate Bio Inc 4.0%unchanged
  10. Willis Towers Watson 3.5%▼ −24.3%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q2 2021

Positions Q2 2021 per 13F filing, 8 of 8
Symbol Weight in previous quarter Shares in previous quarter Value in previous quarter Change
FOXA Fox Corporation (Class A) 2.2% 7,610,818 274.8M USD sold out
FOX Fox Corporation (Class B) 1.6% 5,680,307 198.4M USD sold out
DOC Healthpeak Properties 1.3% 4,966,911 157.7M USD sold out
Colony Cap Inc New 1.3% 24,212,959 156.9M USD sold out
Fidelity National Financial 1.0% 3,036,935 123.5M USD sold out
Reinvent Technology Partners 0.5% 6,000,000 60.2M USD sold out
Thoma Bravo Advantage 0.3% 4,000,000 41.8M USD sold out
Vesper Healthcare Acqstn Cor < 0.1% 1,320,000 2.7M USD sold out
Plus 1 position in convertible bonds and bonds worth 28.6M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 28.6M USD

Breakdown by sector

  • Technology 14.9%
  • Communication Services 10.3%
  • Consumer Discretionary 8.5%
  • Financials 3.5%
  • Materials 2.6%
  • Utilities 2.5%
  • not in our coverage 57.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close